XML 68 R57.htm IDEA: XBRL DOCUMENT v3.19.1
Commitments and Contingencies (Details Narrative) - USD ($)
$ in Thousands
8 Months Ended 12 Months Ended
Aug. 31, 2018
Nov. 17, 2017
Nov. 07, 2017
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Rent expense         $ 115 $ 14
Percentage of net profits payments to third party from sale of product   50.00% 30.00%      
Credit agreement term   10 years 10 years      
Total milestone payments $ 1,104          
Percentage of right to recoup         35.00%  
Payments for development       $ 3,930 $ 5,627  
License Agreement [Member]            
Agreement term         10 years  
Licensor [Member]            
Percentage of net profits payments to third party from sale of product         35.00%  
Percentage of right to recoup         60.00%  
Licensor [Member] | Exclusive License and Supply Agreement [Member]            
Payments for development         $ 350  
Licensor [Member] | Upon FDA Acceptance [Member]            
Payments for development         1,500  
Licensor [Member] | Upon FDA Approval [Member]            
Payments for development         1,000  
Licensor [Member] | Upon Issuance of Patent Covering [Member]            
Payments for development         1,500  
Licensor [Member] | Product Sales [Member]            
Payments for development         500  
Licensor [Member] | Calendar Year [Member]            
Payments for development         $ 10,000